Photo: Shutterstock
With the FDA commissioner set to leave the agency this month, lawyers working with the hemp and CBD industries feel like his departure may lead to a pushback on regulations.
March 06, 2019 at 06:51 PM
1 minute read
U.S. Food and Drug Administration Commissioner Dr. Scott Gottlieb’s impending departure may push back long-awaited regulations on hemp and CBD, according to experts involved in those industries.
Rick Weissman, the president of hemp products maker High Falls Extracts, said Gottlieb, who announced Tuesday he will leave the FDA at the end of the month, supported hemp and CBD regulatory efforts.
Presented by BigVoodoo
General Counsel Summit is the premier event for in-house counsel, hosting esteemed legal minds from all sectors of the economy.
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
WIPL is the original global forum facilitating women-to-women exchange on leadership and legal issues.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
Predictive reporting, trend analysis, peer guidance and a practical playbook to help genetal counsels succeed in their increasingly high stakes roles as risk managers and corporate strategists
